Abstract
Background To date the description of mechanically ventilated patients with Coronavirus Disease 2019 (COVID-19) has focussed on admission characteristics with no consideration of the dynamic course of the disease. Here, we present a data-driven analysis of granular, daily data from a representative proportion of patients undergoing invasive mechanical ventilation (IMV) within the United Kingdom (UK) to evaluate the complete natural history of COVID-19.
Methods We included adult patients undergoing IMV within 48 hours of ICU admission with complete clinical data until death or ICU discharge. We examined factors and trajectories that determined disease progression and responsiveness to ARDS interventions. Our data visualisation tool is available as a web-based widget (https://www.CovidUK.ICU).
Findings Data for 623 adults with COVID-19 who were mechanically ventilated between 01 March 2020 and 31 August 2020 were analysed. Mortality, intensity of mechanical ventilation and severity of organ injury increased with severity of hypoxaemia. Median tidal volume per kg across all mandatory breaths was 5.6 [IQR 4.7-6.6] mL/kg based on reported body weight, but 7.0 [IQR 6.0-8.4] mL/kg based on calculated ideal body weight. Non-resolution of hypoxaemia over the first week of IMV was associated with higher ICU mortality (59.4% versus 16.3%; P<0.001). Of patients ventilated in prone position only 44% showed a positive oxygenation response. Non-responders to prone position show higher D-Dimers, troponin, cardiovascular SOFA, and higher ICU mortality (68.9% versus 29.7%; P<0.001). Multivariate analysis showed prone non-responsiveness being independently associated with higher lactate (hazard ratio 1.41, 95% CI 1.03–1.93), respiratory SOFA (hazard ratio 3.59, 95% CI 1.83–7.04); and cardiovascular SOFA score (hazard ratio 1.37, 95% CI 1.05–1.80).
Interpretation A sizeable proportion of patients with progressive worsening of hypoxaemia were also refractory to evidence-based ARDS strategies and showed a higher mortality. Strategies for early recognition and management of COVID19 patients refractory to conventional management strategies will be critical to improving future outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Imperial College London Covid-19 research fund and the Royal Brompton & Harefield Hospitals Charity.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The United Kingdom Health Research Authority (Bristol Centre) determined that the study be exempt from review by an NHS Research Ethics Committee. Each site registered the study protocol as a service evaluation.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# Joint first authors
↵$ Joint senior authors
↵‡ Collaborators are listed in the supplementary appendix pp 3
* Clinical Science contact – Dr Brijesh V Patel MD PhD. Clinical Senior Lecturer & Consultant in Intensive Care Medicine. Division of Anaesthetics, Pain Medicine & Intensive Care, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London; Department of Adult Intensive Care, The Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London SW3 6NP, email: brijesh.patel{at}imperial.ac.uk
* Data Science contact – Professor A. Aldo Faisal PhD. Professor of AI & Neuroscience. Dept. Of Computing & Dept. Of Bioengineering and Behaviour Analytics Lab, Data Science Institute and UKRI Centre for Doctoral Training in AI for Healthcare, Imperial College London, SW7 2AZ London, UK, and MRC London Institute for Medical Sciences, London W12 0NN UK, email: aldo.faisal{at}imperial.ac.uk
Funding. This study was supported through an internal research grant from the Imperial College London COVID-19 Research Fund to AAF and BVP; and an award from the Royal Brompton & Harefield Hospitals charity to BVP and general support from the NIHR Imperial Biomedical Research Centre. The funders had no role in the study design or writing. All authors had full access to all the data in the study. The writing committee had the sole responsibility for the decision to submit for publication.
Data Availability
All data is available by emailing the corresponding authors.
